A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)

NCT00104364 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: MK0731

Sponsor

Merck Sharp & Dohme LLC